XOMA, Ltd. (NASDAQ: XOMA) is focused on the discovery and development of antibodies, one of the most powerful and transformative fields of drug innovation today. By building on its pioneering proprietary pipeline, antibody discovery and development platform, and multiple revenue streams, the company is creating novel human antibody therapeutics that could revolutionize medicine and reshape people’s lives. For further information, visit the Company’s web site at www.xoma.com.
- 17 years ago
QualityStocks
XOMA, Ltd. (NASDAQ: XOMA)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – DitGold (CRYPTO: DITAU) Gains Exposure as Coinbase Global Inc. (NASDAQ: COIN) Expands DEX Trading Access
DitGold (CRYPTO: DITAU) is now accessible through the Coinbase app decentralized exchange (DEX) functionality, enabling users to…
-
QualityStocksNewsBreaks – Co-Diagnostics, Inc. (NASDAQ: CODX) Expands CoSara Distribution Territory Across South Asia
Co-Diagnostics (NASDAQ: CODX) announced that its Indian joint venture, CoSara Diagnostics Pvt. Ltd., has signed an agreement to expand…
-
QualityStocksNewsBreaks – Brazil Potash Corp. (NYSE-American: GRO) CEO To Speak At IDB Annual Meeting On Global Food Security
Brazil Potash (NYSE-American: GRO) announced that CEO Matt Simpson has been invited to participate as…